5 Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of renal and cardiovascular diseases or conditions; pharmaceutical and biopharmaceutical agents for the treatment of renal and cardiovascular diseases or conditions in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of renal and cardiovascular diseases or conditions in the field of in vivo gene editing therapy